Clinical Importance of the Newly Emerging Influenza A(H3N2) Subclade K as the Dominant Variant
Reviews in Medical Virology · 2026-05 · 36 (3)
DOI: 10.1002/rmv.70150 ↗Kurz gefasst
Leserbrief in der Zeitschrift Reviews in Medical Virology, online erschienen am 20.04.2026. Verfasst von Erta Rajabi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Anesthesia, Critical Care, and Pain Management Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Infectious Diseases, Research Center for Antibiotic Stewardship & Antimicrobial Resistance, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Erta Rajabi, Mohammadreza Salehi
Zitieren
APA
Rajabi, E., Farhadi, K., & Salehi, M. (2026). Clinical Importance of the Newly Emerging Influenza A(H3N2) Subclade K as the Dominant Variant. Reviews in Medical Virology, 36(3). https://doi.org/10.1002/rmv.70150
Vancouver
Rajabi E, Farhadi K, Salehi M. Clinical Importance of the Newly Emerging Influenza A(H3N2) Subclade K as the Dominant Variant. Reviews in Medical Virology. 2026;36(3). doi:10.1002/rmv.70150
BibTeX
@article{Rajabi2026,
author = {Rajabi, Erta and Farhadi, Kousha and Salehi, Mohammadreza},
title = {Clinical Importance of the Newly Emerging Influenza A(H3N2) Subclade K as the Dominant Variant},
journal = {Reviews in Medical Virology},
year = {2026},
volume = {36},
number = {3},
doi = {10.1002/rmv.70150}
}
EUVIMED